48 research outputs found
Quantifying the volume fraction and texture of cancellous bone using 3.0 Tesla magnetic resonance imaging
No full textIntroduction: 3.0 Tesla MRI offers the potential to quantify the volume fraction and structural texture of cancellous bone, along with quantification of marrow composition, in a single non-invasive examination. This study describes our preliminary investigations to identify parameters which describe cancellous bone structure including the relationships between texture and volume fraction.\u
Age, gender, and skeletal variation in bone marrow composition: A preliminary study at 3.0Tesla
No full textSubstitute CT generation from a single ultra short time echo MRI sequence: preliminary study
No full textIn MR guided radiation therapy planning both MR and CT images for a patient are acquired and co-registered to obtain a tissue specific HU map. Generation of the HU map directly from the MRI would eliminate the CT acquisition and may improve radiation therapy planning. In this preliminary study of substitute CT (sCT) generation, two porcine leg phantoms were scanned using a 3D ultrashort echo time (PETRA) sequence and co-registered to corresponding CT images to build tissue specific regression models. The model was created from one co-registered CT-PETRA pair to generate the sCT for the other PETRA image. An expectation maximization based clustering was performed on the co-registered PETRA image to identify the soft tissues, dense bone and air class membership probabilities. A tissue specific non linear regression model was built from one registered CT-PETRA pair dataset to predict the sCT of the second PETRA image in a two-fold cross validation schema. A complete substitute CT is generated in 3 min. The mean absolute HU error for air was 0.3 HU, bone was 95 HU, fat was 30 HU and for muscle it was 10 HU. The mean surface reconstruction error for the bone was 1.3 mm. The PETRA sequence enabled a low mean absolute surface distance for the bone and a low HU error for other classes. The sCT generated from a single PETRA sequence shows promise for the generation of fast sCT for MRI based radiation therapy planning.</p
Imaging performance of a high-field in-line magnetic resonance imaging linear accelerator with a patient rotation system for fixed-gantry radiotherapy
No full textThis paper describes the imaging performance of a high-field in-line MRI linear accelerator with a patient rotation system in-situ. Signal quality was quantified using signal-to-noise ratio (SNR) and RF uniformity maps. B0-field inhomogeneity was assessed using magnetic field mapping. SNR was evaluated with various entries into the Faraday cage which were required for extended couch translations. SNR varied between 103 and 87 across PRS rotation angles. Maximum B0-field inhomogeneity corresponded to 0.7 mm of geometric distortion. A 45 × 55 cm2 aperture allowed PRS translation with no reduction in SNR. Imaging performance with the PRS in-situ was found to be acceptable
Quantification of bone using a 3.0 tesla clinical magnetic resonance scanner
No full textThe work in this thesis examines the potential of using magnetic resonance imaging and spectroscopy (MRI & MRS) as a quantitative tool for diagnosing bone abnormalities at multiple skeletal sites, which could be used in conjunction with routine clinical imaging. MRI and MRS are routinely used in the clinical setting for the diagnosis of various types of diseases and abnormalities due to its advantages of providing excellent soft tissue contrast and also providing physiological and metabolic information. The use of MRI and MRS as a direct diagnostic tool for bone abnormalities is very limited at the moment due to issues of costs and standardisation. The aim in this thesis was to use the clinical 3.0 T MR scanner to acquire data from bone and bone marrow for identification of structural and chemical properties and to use those features to identify differences in bone strength and condition. The volunteers in this thesis were part of the high bone mass (HBM) study and they had additional acquisitions from dual-energy X-ray absorptiometry (DEXA) and peripheral quantitative computed tomography (pQCT). MR acquisition protocols have been successfully optimised for each type of bone region and in-house software has also been created to process the acquired data and quantify various types of structural and chemical properties. The MR data from distal radius and tibia demonstrated good correlation with pQCT data (e.g. Figure 8-2 & Figure 8-3) and were also able to differentiate between HBM-affected and control populations (e.g. Figure 8-26). The MR data from lumbar vertebrae also demonstrated good correlation with DEXA data and some of the measurements were also able to differentiate between the HBM-affected and control populations. The combined results from this thesis demonstrate that both MRI and MRS are sensitive techniques for measurement of bone quantity and quality, and they are ready to be applied for clinical investigation as part of routine clinical imaging to identify bone strength in relation to abnormalities and treatments.EThOS - Electronic Theses Online ServiceYorkshire Cancer Research CampaignGBUnited Kingdo
Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology
No full textOne of the major factors limiting the staging accuracy of conventional magnetic resonance imaging (MRI) for prostatic carcinoma, is the similarity in signal intensity between tumor and coexisting benign prostatic hyperplasia (BPH). As neovascularity is an independent indicator of pathological state, dynamic contrast-enhanced MRI may yield additional information. This study correlates the histopathological findings from 12 radical prostatectomy patients on a region-by-region basis, with pharmacokinetic modeling of dynamic contrast-enhanced (0.2 mmol dimeglumine gadopentetate/kg), fast multiplanar spoilt gradient-recalled echo images, using a two-compartment simplex minimization technique. Quantitative analysis demonstrated differences in the amplitude of the initial contrast upslope and contrast exchange rate between tumor and fibromuscular BPH (P <0.03 and P <0.03, respectively) and for the contrast exchange rate between tumor and fibroglandular BPH (P <0.04), providing improved delineation of intraprostatic tumor extent compared with conventional imaging techniques
Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology
No full textOne of the major factors limiting the staging accuracy of conventional magnetic resonance imaging (MRI) for prostatic carcinoma, is the similarity in signal intensity between tumor and coexisting benign prostatic hyperplasia (BPH). As neovascularity is an independent indicator of pathological state, dynamic contrast-enhanced MRI may yield additional information. This study correlates the histopathological findings from 12 radical prostatectomy patients on a region-by-region basis, with pharmacokinetic modeling of dynamic contrast-enhanced (0.2 mmol dimeglumine gadopentetate/kg), fast multiplanar spoilt gradient-recalled echo images, using a two-compartment simplex minimization technique. Quantitative analysis demonstrated differences in the amplitude of the initial contrast upslope and contrast exchange rate between tumor and fibromuscular BPH (P <0.03 and P <0.03, respectively) and for the contrast exchange rate between tumor and fibroglandular BPH (P <0.04), providing improved delineation of intraprostatic tumor extent compared with conventional imaging techniques
A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy
No full textAdvanced radiotherapy techniques, such as intensity-modulated radiotherapy, have been reported to reduce toxicities by improving the dose conformity in mucosal primary head and neck cancer (MPHNC). However, to further optimize the therapeutic ratio, details on individual patient and disease characteristics may be necessary to tailor treatments. This is likely to include identifying poor responders for treatment intensification and good responders for de-escalation strategies. Non-invasive, repeatable imaging biomarkers are attractive modalities in both pre-treatment and intra-treatment response prediction with a view to individualized treatment options. This review has assessed the current literature on the prognostic/predictive role of widely available functional imaging (FI) studies such as fMRI(functional magnetic resonance imaging), functional computed tomography (fCT) and positron-emission-tomography(PET). A literature search was carried out using Medline, Embase and PubMed. Studies were included if imaging was undertaken pre and/or during radiotherapy (with or without the addition of chemotherapy and/or surgery). A total of 99 relevant studies were identified: 14 fMRI, 10 fCT, 59 FDG-PET and 16 non-FDG-PET studies. These articles were reviewed to identify imaging parameters demonstrating a correlation with patient outcome or a factor considered to impact on patient outcome and thus likely to be of potential predictive value in MPHNC and associated future radiotherapy treatment directions. Several studies have demonstrated that both pre-treatment and mid-treatment FDG-PET is predictive of outcomes. However, further studies are required to confirm the role of other imaging studies including fMRI and PET using other tracers. There is large heterogeneity within and between published studies, including tumour sites, treatment options, outcome endpoints and parameters assessed. We propose a minimum set of factors that should be reported and make recommendations for studies evaluating the predictive utility in MPHNC
